Cargando…

Prophylactic G-CSF in patients with early-stage breast cancer: a health economic review

Although the use of prophylactic granulocyte colony-stimulating factor (G-CSF) in conjunction with myelosuppressive chemotherapy is supported by clinical research evidence and advocated by international clinical guidelines when the consequent risk of febrile neutropenia exceeds 20%, there remains do...

Descripción completa

Detalles Bibliográficos
Autor principal: Trueman, P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752222/
https://www.ncbi.nlm.nih.gov/pubmed/19756001
http://dx.doi.org/10.1038/sj.bjc.6605271